Published in Am J Gastroenterol on August 05, 2008
Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2014) 1.94
Symptomatic reflux disease: the present, the past and the future. Gut (2014) 1.29
NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20
Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters. Am J Gastroenterol (2014) 1.09
Esophageal impedance monitoring for gastroesophageal reflux. J Pediatr Gastroenterol Nutr (2011) 1.08
Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease. World J Gastroenterol (2013) 1.01
Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring. Dig Dis Sci (2010) 0.93
Clinical applications of esophageal impedance monitoring and high-resolution manometry. Curr Gastroenterol Rep (2012) 0.92
Refractory gastroesophageal reflux disease. Gastroenterol Rep (Oxf) (2014) 0.91
Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol (2011) 0.91
Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough. World J Gastroenterol (2013) 0.91
Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease? Ann Gastroenterol (2015) 0.88
The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring. Dig Dis Sci (2010) 0.85
Advances in motility testing--current and novel approaches. Nat Rev Gastroenterol Hepatol (2013) 0.85
EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc (2014) 0.84
Treatment of esophageal (noncardiac) chest pain: an expert review. Clin Gastroenterol Hepatol (2013) 0.83
Management of the patient with incomplete response to PPI therapy. Best Pract Res Clin Gastroenterol (2013) 0.82
Does reflux monitoring with multichannel intraluminal impedance change clinical decision making? J Pediatr Gastroenterol Nutr (2011) 0.81
Advances in diagnostic testing for gastroesophageal reflux disease. World J Gastroenterol (2010) 0.79
Distinction between patients with non-erosive reflux disease and functional heartburn. Ann Gastroenterol (2013) 0.79
Should peri-gastrectomy gastric acidity be our focus among gastric cancer patients? World J Gastroenterol (2014) 0.78
Republished: symptomatic reflux disease: the present, the past and the future. Postgrad Med J (2015) 0.78
Esophageal Impedance Monitoring: Clinical Pearls and Pitfalls. Am J Gastroenterol (2016) 0.78
Management of refractory typical GERD symptoms. Nat Rev Gastroenterol Hepatol (2016) 0.77
In vitro effect of pantoprazole on lower esophageal sphincter tone in rats. World J Gastroenterol (2011) 0.77
The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease. Dig Dis Sci (2013) 0.77
Exertional esophageal pH-metry and manometry in recurrent chest pain. World J Gastroenterol (2010) 0.77
Barrett's esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther (2016) 0.76
Patients with refractory gastroesophageal reflux disease: diagnostic tools. Ann Gastroenterol (2013) 0.75
Prolonged 2-day esophageal pH-metry with impedance monitoring improves symptom-reflux association analysis. Dig Dis Sci (2013) 0.75
Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy. Gastroenterol Hepatol (N Y) (2014) 0.75
Esophageal testing: What we have so far. World J Gastrointest Pathophysiol (2016) 0.75
The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing. Surg Endosc (2013) 0.75
Gastroesophageal reflux disease and obesity: not as simple as we may think. Dig Dis Sci (2012) 0.75
A Review of Esophageal Chest Pain. Gastroenterol Hepatol (N Y) (2015) 0.75
The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clin Transl Gastroenterol (2015) 0.75
Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy. Clinicoecon Outcomes Res (2013) 0.75
Proton pump inhibitors for reflux therapy in infants: effectiveness determined by impedance pH monitoring. Pediatr Surg Int (2014) 0.75
A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med (2010) 7.83
Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: a randomized trial. JAMA (2012) 3.47
Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology (2013) 2.67
Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc (2009) 2.23
Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure. Am J Gastroenterol (2008) 2.04
Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol (2011) 1.91
Erroneous diagnosis of gastroesophageal reflux disease in achalasia. Clin Gastroenterol Hepatol (2011) 1.81
Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux. Gastroenterology (2006) 1.73
The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol (2010) 1.73
Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology (2013) 1.71
Two siblings with lichen planus and squamous cell carcinoma of the oesophagus. Eur J Gastroenterol Hepatol (2006) 1.65
IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci (2004) 1.53
Fully covered self-expandable metal stents (SEMS), partially covered SEMS and self-expandable plastic stents for the treatment of benign esophageal ruptures and anastomotic leaks. BMC Gastroenterol (2012) 1.50
Impact of surgeon experience on 5-year outcome of laparoscopic Nissen fundoplication. Arch Surg (2011) 1.48
Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett's esophagus. Gastroenterology (2010) 1.47
Quality of life of patients with irritable bowel syndrome is low compared to others with chronic diseases. Eur J Gastroenterol Hepatol (2006) 1.45
Effect of peroral endoscopic myotomy on esophagogastric junction physiology in patients with achalasia. Gastrointest Endosc (2013) 1.36
Technology review: Esophageal impedance monitoring. Am J Gastroenterol (2006) 1.31
Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol (2006) 1.28
Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm. Gastrointest Endosc (2011) 1.22
Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial. Ann Surg (2009) 1.19
Air swallowing, belching, and reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol (2006) 1.14
Multichannel intraluminal impedance monitoring in the evaluation of patients with non-obstructive Dysphagia. Am J Gastroenterol (2005) 1.12
Supragastric belching in patients with reflux symptoms. Am J Gastroenterol (2009) 1.12
Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasia. Gastrointest Endosc (2011) 1.11
Psychological factors affect the frequency of belching in patients with aerophagia. Am J Gastroenterol (2006) 1.11
Prevalence of mabDAS-1 positivity in biopsy specimens from the esophagogastric junction. Am J Gastroenterol (2002) 1.10
Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol (2005) 1.07
Randomized, blinded comparison of transgastric, transcolonic, and laparoscopic peritoneoscopy for the detection of peritoneal metastases in a human cadaver model. Gastrointest Endosc (2010) 1.07
EUS-guided endoscopic transgastric necrosectomy in patients with infected necrosis in acute pancreatitis. Pancreatology (2008) 1.06
Water-perfused esophageal high-resolution manometry: normal values and validation. Am J Physiol Gastrointest Liver Physiol (2014) 1.02
Transluminal endoscopic step-up approach versus minimally invasive surgical step-up approach in patients with infected necrotising pancreatitis (TENSION trial): design and rationale of a randomised controlled multicenter trial [ISRCTN09186711]. BMC Gastroenterol (2013) 1.02
Early laparoscopic cholecystectomy improves outcomes after endoscopic sphincterotomy for choledochocystolithiasis. Gastroenterology (2010) 1.01
Physiologic and pathologic belching. Clin Gastroenterol Hepatol (2007) 1.01
Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology (2013) 1.01
The Visick score: a good measure for the overall effect of antireflux surgery? Scand J Gastroenterol (2008) 0.99
Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology (2006) 0.99
Gastro-oesophageal reflux disease. Lancet (2013) 0.99
Timing of cholecystectomy after endoscopic sphincterotomy for common bile duct stones. Surg Endosc (2008) 0.99
Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association. J Clin Gastroenterol (2008) 0.98
Independent predictors of survival in patients with incurable malignant gastric outlet obstruction: a multicenter prospective observational study. Scand J Gastroenterol (2010) 0.98
Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial. BMC Gastroenterol (2013) 0.98
Colonic stenting as bridge to surgery versus emergency surgery for management of acute left-sided malignant colonic obstruction: a multicenter randomized trial (Stent-in 2 study). BMC Surg (2007) 0.97
Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease. Scand J Gastroenterol (2007) 0.97
Effect of inhibition of inducible nitric oxide synthase and guanylyl cyclase on endotoxin-induced delay in gastric emptying and intestinal transit in mice. Shock (2002) 0.96
Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study. Eur J Gastroenterol Hepatol (2008) 0.95
Detection of small-bowel neuroendocrine tumors by video capsule endoscopy. Gastrointest Endosc (2006) 0.94
Diagnostic yield of oesophageal pH monitoring in patients with chronic unexplained cough. Scand J Gastroenterol (2008) 0.93
Clinical applications of esophageal impedance monitoring and high-resolution manometry. Curr Gastroenterol Rep (2012) 0.92
Esophageal disorders. Am J Gastroenterol (2010) 0.91
Aerophagia and rumination: recognition and therapy. Curr Treat Options Gastroenterol (2006) 0.91
Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr (2003) 0.90
Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer. Am J Clin Nutr (2007) 0.90
The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am J Gastroenterol (2004) 0.90
Effect of sleeve gastrectomy on gastroesophageal reflux. Obes Surg (2014) 0.89
Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation. Eur J Gastroenterol Hepatol (2013) 0.89
Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study). BMC Surg (2009) 0.88
Quality of life and illness costs in irritable bowel syndrome. Digestion (2004) 0.88
The preoperative reflux pattern as prognostic indicator for long-term outcome after Nissen fundoplication. Am J Gastroenterol (2009) 0.87
The additional value of EUS-guided Tru-cut biopsy to EUS-guided FNA in patients with mediastinal lesions. Gastrointest Endosc (2009) 0.86
Endoscopic corticosteroid injections do not reduce dysphagia after endoscopic dilation therapy in patients with benign esophagogastric anastomotic strictures. Clin Gastroenterol Hepatol (2013) 0.86
Advances in motility testing--current and novel approaches. Nat Rev Gastroenterol Hepatol (2013) 0.85
Characteristics of gastroesophageal reflux in symptomatic patients with and without excessive esophageal acid exposure. Am J Gastroenterol (2006) 0.85
Aspiration and allograft injury secondary to gastroesophageal reflux occur in the immediate post-lung transplantation period (prospective clinical trial). Ann Surg (2013) 0.84
Fish consumption and markers of colorectal cancer risk: a multicenter randomized controlled trial. Am J Clin Nutr (2009) 0.84
Reliability of oesophageal pH recording for the detection of gastro-oesophageal reflux. Scand J Gastroenterol (2008) 0.83
Reproducibility of symptom association analysis in ambulatory reflux monitoring. Am J Gastroenterol (2008) 0.83
Gas-related symptoms after antireflux surgery. Surg Endosc (2013) 0.83
The role of hiatus hernia in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol (2004) 0.83
The influence of laparoscopic adjustable gastric banding on gastroesophageal reflux. Obes Surg (2004) 0.82
Endoscopic necrosectomy in necrotising pancreatitis: indication is the key. Gut (2010) 0.82